Melmed S. Medical progress: acromegaly. N Engl J Med 2006; 355: 2558–2573.
Freda PU. Current concepts in the biochemical assessment of the patient with acromegaly. Growth Horm IGF Res 2003; 13: 171–184.
Colao A. Long-term complications of acromegaly. In: Wass JAH, editor. Acromegaly. Bristol: BioScientifica; 2009: 55–77.
Kreze A, Kreze-Spirova E, Mikulecky M. Risk factors for glucose intolerance in active acromegaly. Braz J Med Biol Res 2001; 34: 1429–1433.
Nikkila EA, Pelkonen R. Serum lipids in acromegaly. Metabolism 1975; 24: 829–838.
Baldelli R, De Marinis L, Bianchi A. Microalbuminuria in insulin sensitivity in patients with growth hormone-secreting pituitary tumor. J Clin Endocrinol Metab 2008; 93: 710–714.
Colao A, Ferone D, Marzullo P. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 2004; 25: 102–152.
Hermann BL, Brandt-Mainz K, Saller B. Myocardial perfusion abnormalities in patients with active acromegaly. Horm Metab Res 2003; 35: 183–188.
Dostalova S, Sonka K, Smahel Z. Craniofacial abnormalities and their revelance for sleep apnea syndrome aethiopathogenesis in acromegaly. Eur J Endocrinol 2001; 144: 491–497.
Rokkas T, Pistiolas D, Sechopoulos P. Risk of colonorectal neoplasm in patients with acromegaly: a meta-analysis.World J Gastroenterol 2008; 14: 3484–3489.
Collao A, Marzullo P, Ferone D. Prostatic hyperplasia: an unknown feature of acromegaly. J Clin Endocrinol Metab 2998; 83: 1986–1991.
Beckers A, Daly AF. The epidemiology of acromegaly. In: Wass JAH, editor. Acromegaly. Bristol: BioScientifica; 2009:13–18.
Colao A. The GH -IGF-I axis and the cardiovascular system: clinical implications. Clin Endocrinol 2008; 69: 347–358.
R enehan AG, Bhaskar P, Painter JE. The prevalence and characteristics of colonorectal neoplasia in acromegaly. J Clin Endocrinol Metab 2000; 85: 3417–3424.